Detalhe da pesquisa
1.
Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses.
PLoS Pathog
; 19(4): e1010870, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37079651
2.
High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster.
J Infect Dis
; 226(8): 1401-1406, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723969
3.
UB-612 pan-SARS-CoV-2 T cell immunity-promoting vaccine protects against COVID-19 moderate-severe disease.
iScience
; 27(2): 108887, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38318376
4.
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.
Emerg Microbes Infect
; 11(1): 2724-2734, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36287714
5.
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants.
J Clin Invest
; 132(10)2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316221
6.
UB-311, a novel UBITh® amyloid ß peptide vaccine for mild Alzheimer's disease.
Alzheimers Dement (N Y)
; 3(2): 262-272, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29067332
7.
Target integration by a chimeric Sp1 zinc finger domain-Moloney murine leukemia virus integrase in vivo.
J Biomed Sci
; 9(2): 171-84, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-11914585